HopeStage
Back to all studies
TerminatedNCT01526148

Gao Bipolar Spectrum Lithium/Quetiapine Study

This study evaluates the safety and effectiveness of lithium for people with bipolarity.

Medication studyAges 18+United States
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of lithium for people with bipolarity.

Who could participate?

Listed age limits: from 18 years.

Listed locations
ClevelandSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJanuary 2012
Recruitment status
Terminated
Enrollment listed in the registry
42
Sponsor
University Hospitals Cleveland Medical Center
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT01526148
Official title
Show the full official title

Comparative Safety, Tolerability, and Effectiveness of Lithium Versus Quetiapine in Patients Across the Spectrum of Bipolar Disorder

Recruitment & locations

Terminated

Cleveland

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of lithium for people with bipolarity.

Who is behind this study?

The study sponsor is University Hospitals Cleveland Medical Center, a university.

Does this study involve medication?

Yes. The study involves medication, including lithium and Quetiapine.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies